99% Savings - Buy Just @1 Rs X
Lycomerve NT Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Lycomerve NT Tablet safe for pregnant women?
Lycomerve NT Tablet may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Lycomerve NT Tablet again without your doctor's advice.
Is the use of Lycomerve NT Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Lycomerve NT Tablet. It should only be taken after medical advice.
What is the effect of Lycomerve NT Tablet on the Kidneys?
Lycomerve NT Tablet has very mild side effects on the kidneys.
What is the effect of Lycomerve NT Tablet on the Liver?
Lycomerve NT Tablet is completely safe for the liver.
What is the effect of Lycomerve NT Tablet on the Heart?
You can take Lycomerve NT Tablet without any fear of damage to the heart.
Lycomerve NT Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Lycomerve NT Tablet unless your doctor advises you to do so -
Is this Lycomerve NT Tablet habit forming or addictive?
Lycomerve NT Tablet does not cause addiction.
Interaction between Food and Lycomerve NT Tablet
It is safe to take Lycomerve NT Tablet with food.
Interaction between Alcohol and Lycomerve NT Tablet
Taking Lycomerve NT Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420